Epigral Ltd Closes Trading Window for Q2 FY27 Results

Epigral Limited has announced the closure of its trading window for all insiders, directors, promoters, designated persons, and their immediate relatives. This closure is in accordance with SEBI (Prohibition of Insider Trading) Regulations, 2015, and the company's internal code. The trading window will remain shut from October 1, 2026, until 48 hours after the declaration of the Un-Audited Financial Results for the Second Quarter and Half Year ended September 30, 2026. The company is utilizing Central Depository Service Limited to freeze PAN at the security level for its ISIN to restrict trading by designated persons and their relatives, adhering to recent SEBI circulars. The date for the Board Meeting to approve these financial results will be announced later.